tabelecleucel
atara biotherapeutics,pierre fabre
['tab-cel', 'atara ']
during this year's #ash22, atara presented data on our investigational therapy, tab-cel including updated interim analysis &amp; safety results from our phase 3 allele study in r/r #ebv+ #ptld as well as efficacy &amp; safety data in ebv+ #leiomyosarcomas. more: 
Atara Biotherapeutics $ATRA develops next-gen #CART therapies & off-the-shelf allogeneic #TCellRx #immunotherapy for cancer & #MS #EBV+ #PTLD #celltherapy